Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SFRP1 | Q8N474 | 2/20 | 0.86 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | BRD4 | O60885 | 1/20 | 0.54 |
| ▸ | BRD2 | P25440 | 1/20 | 0.54 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4617285 | 0.96 | SFRP1 (0.84) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4618887 | 0.94 | SFRP1 (0.75) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4616099 | 0.93 | SFRP1 (1.00) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4618605 | 0.91 | SFRP1 (0.71) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4617746 | 0.91 | SFRP1 (0.70) | SFRP1TAAR1TDP1ALDH1A1POLB | |
| SCHEMBL4619649 | 0.91 | SFRP1 (0.70) | SFRP1TAAR1TDP1ALDH1A1POLB | |
| SCHEMBL4616903 | 0.90 | SFRP1 (0.90) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4617599 | 0.90 | SFRP1 (0.80) | SFRP1TAAR1TDP1BRD4BRD2 | |
| SCHEMBL4618849 | 0.88 | SFRP1 (0.67) | SFRP1TAAR1TDP1ALDH1A1POLB | |
| SCHEMBL4617050 | 0.88 | SFRP1 (0.67) | SFRP1TAAR1TDP1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | claimed |
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | SFRP1, SOS1, FZD7 | SFRP1 1/4885TAAR1 3692/4885TDP1 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.